Used in pharmaceutical research as a key intermediate in the synthesis of nicotinic acetylcholine receptor (nAChR) modulators. It serves as a structural building block for compounds targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its azetidine-pyridine scaffold is valued for enhancing blood-brain barrier penetration and improving metabolic stability in drug candidates. Also employed in the development of novel antidepressants and cognitive enhancers due to its favorable binding affinity to central nervous system receptors.